CD4 and COVID-19: Future studies with an enhanced transfection efficiency of TCRs and corresponding detailed functional verification in vivo may significantly increase the efficacy of SARS-CoV-2-specific CD4+ TCR-T cells and help us to better evaluate this potential therapeutic method for treating COVID-19 patients.